Schedule 13G ownership disclosure
ACHILLION PHARMACEUTICALS INC
Security class unavailable · CUSIP: 00448Q201
Event date: 2014-09-24
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 11,032,014
- Percent of class
- 11.3000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001144204-14-058127
- Form type
- SC 13G
- Filer
- ACHILLION PHARMACEUTICALS INC
- CIK
- CIK 1070336
- Filed
- Sep 26, 2014
- Reporting period
- Sep 24, 2014
- Description
- Schedule 13G beneficial ownership